HOME › DRUGS › ANIFROLUMAB
ACTIVE SUBSTANCE / INN

ANIFROLUMAB

Brand name(s): Saphnelo
EMA LISTED
AUTHORISED
Lupus Erythematosus, Systemic
ACTIVE SUBSTANCE
Anifrolumab
REGULATORS
EMA
SPONSORS / MAH
AstraZeneca AB
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SaphneloAstraZeneca ABAuthorised14/02/2022Lupus Erythematosus, Systemic

FULL INTELLIGENCE ON ANIFROLUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →